Technology area: Medical Devices & Mechanical Engineering
5 pending office actions • 1 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Medela Holding AG is managing 4 pending office actions within the Medical Devices & Mechanical Engineering technology area. These 4 actions are assigned to 4 distinct examiners, which indicates that no single examiner is reviewing more than 1 application for the company at this time. This distribution ensures that each matter receives attention from a different official.
All 4 pending office actions are concentrated within 1 distinct art unit, showing a high degree of technical focus despite the involvement of multiple examiners. AHMED, TASNIM M is the busiest examiner for the portfolio, with 1 pending office action. This workload of 1 pending office action is consistent across the distinct examiners assigned to the company's matters. The combination of the pending workload and the 1 distinct art unit suggests that the company's current filings are technically similar enough to be grouped together by the patent office.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (20%) |
| Multi-statute (no §101) | 4 (80%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| AHMED, TASNIM M | 1 | 81.1% | +5.2% |
| RODRIGUEZ, CRIS LOIREN | 1 | 26.3% | +11.4% |
| PATEL, SHEFALI DILIP | 1 | 58.0% | +27.7% |
| FREDRICKSON, COURTNEY B | 1 | 75.6% | +29.5% |
| WITTLIFF, KATERINA ANNA | 1 | 35.0% | +18.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18288736 | Breast Pump | PATEL, SHEFALI DILIP | 28d |
| 18642607 | BREAST PUMP | AHMED, TASNIM M | — |
| 18641143 | Breast Pump | RODRIGUEZ, CRIS LOIREN | — |
| 18081523 | BREAST SHIELD | FREDRICKSON, COURTNEY B | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18288736 | Breast Pump | PATEL, SHEFALI DILIP | 28d |
| 17720891 | SYSTEM FOR OPTIMIZING PUMPING SESSION SUCCESS | WITTLIFF, KATERINA ANNA | 41d |
| 18641143 | Breast Pump | RODRIGUEZ, CRIS LOIREN | — |
| 18081523 | BREAST SHIELD | FREDRICKSON, COURTNEY B | — |
| Art Unit | Apps |
|---|---|
| 3783 | 3 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18642607 | BREAST PUMP | AHMED, TASNIM M | — | §102§112 | Non-Final OA | — | Pending | Apr 22, 2024 |
| 18641143 | Breast Pump | RODRIGUEZ, CRIS LOIREN | — | §102§112 | Non-Final OA | — | Pending | Apr 19, 2024 |
| 18288736 | Breast Pump | PATEL, SHEFALI DILIP | 3783 | §102§103§112 | Final Rejection | 28d | Pending | Oct 27, 2023 |
| 18081523 | BREAST SHIELD | FREDRICKSON, COURTNEY B | 3783 | §102§103§112 | Final Rejection | — | Pending | Dec 14, 2022 |
| 17720891 | SYSTEM FOR OPTIMIZING PUMPING SESSION SUCCESS | WITTLIFF, KATERINA ANNA | 3783 | §103 | Final Rejection | 41d | Pending | Apr 14, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial